Toxoplasma Gondii antibody

Catalog No. ABIN319160

The Goat Polyclonal anti-Toxoplasma Gondii antibody is suitable to detect Toxoplasma Gondii in samples from Toxoplasma gondii. It has been validated for IF.

Quick Overview for Toxoplasma Gondii antibody (ABIN319160)

Target: Toxoplasma Gondii

Reactivity: Toxoplasma gondii

Host: Goat

Clonality: Polyclonal

Conjugate: This Toxoplasma Gondii antibody is un-conjugated

Application: Immunofluorescence (IF)

Product Details anti-Toxoplasma Gondii Antibody

Purification: Purified

Immunogen: Tachyzoites of RH strain of Toxoplasma gondii.

Isotype: IgG

Application Details

Application Notes: Immunofluorescence.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 4-5 mg/mL

Buffer: Phosphate buffered saline containing 0.09 % Sodium Azide (NaN3)

Preservative: Sodium azide

Precaution of Use: This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Handling Advice: Avoid repeated freezing and thawing.

Storage: 4 °C/-20 °C

Storage Comment: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Target Details for Toxoplasma Gondii

Target: Toxoplasma Gondii

Target Type: Species

Background: Felids are the only definitive host for T. gondii.. Infection is usually sub-clinical with symptoms depending on the level of tachyzoite release, the ability of the host to limit tachyzoite spread and the organs damaged by the tachyzoites. Immunocompetent adult animals generally limit tachyzoite spread and infection remains subclinical. However in young or immunocompromised animals infection can develop to an acute gereralised toxoplasmosis. T. gondii is an important zoonotic agent with up to 60 % of some human populations demonstrating Serum IgG titers to the organism. These are likely to be persistently infected. The organism is of particular concern in immunocomprimised individuals such as those with HIV infection, who become increasingly susceptible to the organism as the immune system wanes. Infection is also of considerable concern in pregnant women as it can migrate across the placenta and cause birth defects in human foetuses.